Related Experiment Video
Updated: Aug 5, 2025
Zika Virus Specific Diagnostic Epitope Discovery
Published on: December 12, 2017
Identification of Zika Virus NS1-Derived Peptides with Potential Applications in Serological Tests
Carlos Roberto Prudencio1, Vivaldo Gomes da Costa2, Leticia Barboza Rocha3
1Laboratório de Imunobiotecnologia, Centro de Imunologia, Instituto Adolfo Lutz, Av. Dr. Arnaldo, 351, São Paulo 01246-902, SP, Brazil.
Abstract:
Zika virus (ZIKV), a mosquito-borne pathogen, is an emerging arbovirus associated with sporadic symptomatic cases of great medical concern, particularly among pregnant women and newborns affected with neurological disorders. Serological diagnosis of ZIKV infection is still an unmet challenge due to the co-circulation of the dengue virus, which shares extensive sequence conservation of structural proteins leading to the generation of cross-reactive antibodies. In this study, we aimed to obtain tools for the development of improved serological tests for the detection of ZIKV infection. Polyclonal sera (pAb) and a monoclonal antibody (mAb 2F2) against a recombinant form of the ZIKV nonstructural protein 1 (NS1) allowed the identification of linear peptide epitopes of the NS1 protein. Based on these findings, six chemically synthesized peptides were tested both in dot blot and ELISA assays using convalescent sera collected from ZIKV-infected patients. Two of these peptides specifically detected the presence of ZIKV antibodies and proved to be candidates for the detection of ZIKV-infected subjects. The availability of these tools opens perspectives for the development of NS1-based serological tests with enhanced sensitivity regarding other flaviviruses.
Insights
Developing accurate Zika virus (ZIKV) diagnostics is crucial. This study identified two specific peptides from the ZIKV NS1 protein that can detect ZIKV antibodies, aiding in improved serological test development.
Area of Science:
- Virology
- Immunology
- Diagnostic Development
Background:
- Zika virus (ZIKV) is a mosquito-borne pathogen causing significant health concerns, especially neurological disorders in pregnant women and newborns.
- Serological diagnosis of ZIKV is challenging due to cross-reactivity with Dengue virus (DENV) antibodies.
- Development of specific diagnostic tools for ZIKV is an unmet need.
Purpose of the Study:
- To develop improved tools for serological detection of ZIKV infection.
- To identify specific peptide epitopes of the ZIKV nonstructural protein 1 (NS1).
Main Methods:
- Generation of polyclonal sera (pAb) and a monoclonal antibody (mAb 2F2) against recombinant ZIKV NS1.
- Identification of linear peptide epitopes on the ZIKV NS1 protein.
- Chemical synthesis and testing of six peptides using dot blot and ELISA assays with patient convalescent sera.
Main Results:
- Two synthesized peptides specifically detected ZIKV antibodies in patient sera.
- These peptides demonstrated potential as candidates for ZIKV detection.
- The identified epitopes are specific and minimize cross-reactivity with other flaviviruses.
Conclusions:
- The study successfully identified specific peptide epitopes from ZIKV NS1.
- These peptides serve as valuable tools for developing sensitive and specific NS1-based serological tests for ZIKV.
- This advancement offers improved diagnostic capabilities for ZIKV infection, differentiating it from other flaviviruses.
